RTI Surgical Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
197,979.00
262,810.00
282,293.00
272,865.00
279,563.00
280,855
Cost of Goods Sold (COGS) incl. D&A
119,674.00
129,013.00
132,551.00
140,516.00
137,042.00
140,732
Gross Income
78,305.00
133,797.00
149,742.00
132,349.00
142,521.00
140,123
SG&A Expense
93,976.00
123,189.00
122,504.00
136,045.00
128,478.00
133,627
EBIT
15,671.00
10,608.00
-
3,696.00
14,043.00
6,496
Unusual Expense
12,985.00
4,983.00
2,613.00
11,985.00
19,323.00
12,306
Non Operating Income/Expense
251.00
88.00
78.00
132.00
34,177.00
2,965
Interest Expense
542.00
1,357.00
1,492.00
1,655.00
3,180.00
2,771
Pretax Income
28,924.00
4,189.00
23,214.00
17,460.00
25,725.00
5,581
Income Tax
11,110.00
1,493.00
8,299.00
3,061.00
19,453.00
4,331
Consolidated Net Income
17,814.00
2,696.00
14,915.00
14,399.00
6,272.00
1,250
Net Income
17,814.00
2,696.00
14,915.00
14,399.00
6,272.00
1,250
Net Income After Extraordinaries
17,814.00
2,696.00
14,915.00
14,399.00
6,272.00
1,250
Net Income Available to Common
19,189.00
417.00
11,610.00
17,907.00
2,549.00
3,370
EPS (Basic)
0.34
0.01
0.20
0.31
0.04
0.05
Basic Shares Outstanding
56,258.60
56,735.90
57,611.20
58,236.70
59,684.30
63,521.70
EPS (Diluted)
0.34
0.01
0.20
0.31
0.04
0.05
Diluted Shares Outstanding
56,258.60
56,735.90
58,590.50
58,236.70
60,600.00
63,521.70
EBITDA
3,469.00
26,003.00
43,760.00
12,814.00
28,269.00
21,065
Non-Operating Interest Income
23.00
9.00
3.00
8.00
8.00
35
Preferred Dividends
1,375.00
3,113.00
3,305.00
3,508.00
3,723.00
2,120

About RTI Surgical

View Profile
Address
11621 Research Circle
Alachua Florida 32615
United States
Employees -
Website http://www.rtix.com
Updated 07/08/2019
RTI Surgical, Inc. is a global surgical implant company providing surgeons with biologic, metal and synthetic implants. It operates through the following business lines: Spine, Sports Medicine and Orthopedics, Surgical Specialties, Cardiothoracic, International, and Global Commercial. The Spine business line designs, manufactures, and distributes surgical implants, instruments, and biologics used in the treatment of conditions affecting the spine caused by degenerative conditions, deformities or traumatic injury.